Condensed Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023		118,210,315
Beginning balance at Dec. 31, 2023	$ (454,994)	$ 118	$ 1,149,170	$ (1,549,284)	$ 0	$ (54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		439,783
Vesting of restricted stock units and performance-based restricted stock units	1	$ 1
Stock-based compensation	3,235		3,235
Issuance of common stock from offering, net of issuance costs (in shares)		65,205,000
Issuance of common stock from offering, net of issuance costs	90,672	$ 65	90,607
Exercise of warrants (in shares)		4,000,000
Exercise of warrants	5,766	$ 4	5,762
Net income (loss)	61,022			61,022
Ending balance (in shares) at Mar. 31, 2024		187,855,098
Ending balance at Mar. 31, 2024	(294,298)	$ 188	1,248,774	(1,488,262)	0	(54,998)
Beginning balance (in shares) at Dec. 31, 2023		118,210,315
Beginning balance at Dec. 31, 2023	(454,994)	$ 118	1,149,170	(1,549,284)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(30,427)
Ending balance (in shares) at Sep. 30, 2024		195,440,498
Ending balance at Sep. 30, 2024	(370,209)	$ 195	1,264,305	(1,579,711)	0	(54,998)
Beginning balance (in shares) at Mar. 31, 2024		187,855,098
Beginning balance at Mar. 31, 2024	(294,298)	$ 188	1,248,774	(1,488,262)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		479,921
Vesting of restricted stock units and performance-based restricted stock units	1	$ 1
Stock-based compensation	2,931		2,931
Exercise of stock options (in shares)		17,606
Exercise of stock options	29		29
Exercise of warrants (in shares)		6,272,783
Exercise of warrants	9,042	$ 6	9,036
Net income (loss)	(61,925)			(61,925)
Ending balance (in shares) at Jun. 30, 2024		194,625,408
Ending balance at Jun. 30, 2024	(344,220)	$ 195	1,260,770	(1,550,187)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		436,188
Stock-based compensation	3,022		3,022
Issuance of common stock from offering, net of issuance costs (in shares)		378,902
Issuance of common stock from offering, net of issuance costs	513		513
Net income (loss)	(29,524)			(29,524)
Ending balance (in shares) at Sep. 30, 2024		195,440,498
Ending balance at Sep. 30, 2024	(370,209)	$ 195	1,264,305	(1,579,711)	0	(54,998)
Beginning balance (in shares) at Dec. 31, 2024		195,852,463
Beginning balance at Dec. 31, 2024	(388,722)	$ 196	1,267,109	(1,601,029)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		461,779
Vesting of restricted stock units and performance-based restricted stock units	1	$ 1
Vesting of ESPP Shares (in shares)		346,129
Vesting of ESPP shares	500		500
Stock-based compensation	2,465		2,465
Net income (loss)	(40,455)			(40,455)
Ending balance (in shares) at Mar. 31, 2025		196,660,371
Ending balance at Mar. 31, 2025	(426,211)	$ 197	1,270,074	(1,641,484)	0	(54,998)
Beginning balance (in shares) at Dec. 31, 2024		195,852,463
Beginning balance at Dec. 31, 2024	$ (388,722)	$ 196	1,267,109	(1,601,029)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Exercise of stock options (in shares)	36,160
Net income (loss)	$ (84,513)
Ending balance (in shares) at Sep. 30, 2025		205,430,219
Ending balance at Sep. 30, 2025	(451,361)	$ 205	1,288,974	(1,685,542)	0	(54,998)
Beginning balance (in shares) at Mar. 31, 2025		196,660,371
Beginning balance at Mar. 31, 2025	(426,211)	$ 197	1,270,074	(1,641,484)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		829,390
Vesting of restricted stock units and performance-based restricted stock units	0
Stock-based compensation	2,669		2,669
Issuance of common stock from offering, net of issuance costs (in shares)		2,665,505
Issuance of common stock from offering, net of issuance costs	2,758	$ 3	2,755
Net income (loss)	(12,725)			(12,725)
Ending balance (in shares) at Jun. 30, 2025		200,155,266
Ending balance at Jun. 30, 2025	(433,509)	$ 200	1,275,498	(1,654,209)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		673,398
Vesting of restricted stock units and performance-based restricted stock units	1	$ 1
Vesting of ESPP Shares (in shares)		350,745
Vesting of ESPP shares	470		470
Stock-based compensation	2,349		2,349
Issuance of common stock from offering, net of issuance costs (in shares)		4,170,000
Issuance of common stock from offering, net of issuance costs	10,520	$ 4	10,516
Exercise of stock options (in shares)		80,810
Exercise of stock options	141		141
Net income (loss)	(31,333)			(31,333)
Ending balance (in shares) at Sep. 30, 2025		205,430,219
Ending balance at Sep. 30, 2025	$ (451,361)	$ 205	$ 1,288,974	$ (1,685,542)	$ 0	$ (54,998)